| 000 | 01840 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516052922.0 | ||
| 264 | 0 | _c20120404 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1532-8600 | ||
| 024 | 7 |
_a10.1016/j.metabol.2011.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMori, Yusaku | |
| 245 | 0 | 0 |
_aEzetimibe alone or in combination with pitavastatin prevents kidney dysfunction in 5/6 nephrectomized rats fed high-cholesterol. _h[electronic resource] |
| 260 |
_bMetabolism: clinical and experimental _cMar 2012 |
||
| 300 |
_a379-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _xmetabolism |
| 650 | 0 | 4 |
_aAzetidines _xtherapeutic use |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, Dietary _xpharmacology |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCreatinine _xmetabolism |
| 650 | 0 | 4 |
_aDeoxyguanosine _xmetabolism |
| 650 | 0 | 4 | _aEzetimibe |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 |
_aKidney Diseases _xetiology |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aProteinuria _xmetabolism |
| 650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
| 650 | 0 | 4 |
_aRNA _xbiosynthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aHirano, Tsutomu | |
| 773 | 0 |
_tMetabolism: clinical and experimental _gvol. 61 _gno. 3 _gp. 379-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.metabol.2011.07.004 _zAvailable from publisher's website |
| 999 |
_c21110672 _d21110672 |
||